Number 83

‘Me doctor, you patient’ – can’t we do better than that?

Editorial 24 September 2018 1

While holidaying on the Greek island of Ithaca, where the Odyssey ended, I met a man of my age and my country who had just finished his treatment for colorectal cancer. He now lives on Ithaca most of the year, returning home only ... [ more ]

Tumour microenvironment the new battlespace in the war against cancer

Cover Story, Featured 24 September 2018 0

No cancer cell can survive, thrive, proliferate, infiltrate or metastasise without concerted help from the tumour microenvironment (TME). So shouldn’t treatment strategies aim to modify what’s happening around the cancer as much a... [ more ]

Beating cancer at its own game

Cutting Edge, Featured 24 September 2018 0

Game theory has been used to understand economics, ecology and evolution. It is now being used to try to help us outwit cancer. Sophie Fessl asks: will evolutionary game theory guide the way to a more strategic use of available ca... [ more ]

Thierry Philip – President, Organisation of European Cancer Institutes

hot seat 24 September 2018 0

Whether you are a designated cancer centre leading international translational research projects, or a cancer service working to deliver high-quality treatment at a university hospital, the Organisation of European Cancer Institut... [ more ]

Need a doctor? Send in your digital twin!

Featured, Spotlight on 24 September 2018 0

Max Rauner, Science editor at ZEIT Wissen, the popular science magazine of Germany’s largest weekly newspaper Die ZEIT, won the Cancer World Journalism Award for best article on research, with this piece on the use of modelling ‘v... [ more ]

Primary therapy of early oesophageal and gastric cancers

Grandround 24 September 2018 0

What does our growing understanding of the molecular subtypes of gastric and oesophageal cancers, and the results of recent trials testing multimodal therapies, mean for the way we classify, diagnose and treat these tumours? Jonas... [ more ]

Hopes for faster access to beneficial new drugs hang in the balance

Featured, Spotlight on 24 September 2018 0

After more than ten years developing and piloting a collaborative approach to evaluating new medical technologies, EUnetHTA will come to an end in 2020. The Commission is proposing a replacement with mandatory powers, but are Euro... [ more ]

The personalisation lottery – Lack of accessible regulated testing services is putting patients and health budgets at risk

Featured, Systems & Services 24 September 2018 0

Health systems and insurances take decisions on reimbursing targeted medicines, doctors focus increasingly on tailoring treatments to individual patients and the molecular biology of their disease. But the need for funded quality-... [ more ]

Helen Boyle: putting personalised care into practice

Profile 24 September 2018 0

Whether the patient in front of her is old and frail, young and trying to keep their life on track, or simply struggling to come to terms with a terminal diagnosis, Helen Boyle goes the extra mile to ensure each one gets the care ... [ more ]

When patients ask you to help them die

Featured, Spotlight on 24 September 2018 0

The public, politicians, and legislators debate the morals, ethics, and unintended consequences of assisted dying. But it is clinicians, in the privacy of their consulting room, who face requests to be the person giving that assis... [ more ]